Stay informed with the latest litigation news. Explore now

IP Verse

Methods And Medicament For Inhibition The Expression Of A Defined Gene - EP1798285B1

EP1798285

ALNYLAM EUROPE
Application Number
EP06025389A
Filing Date
Jan 29, 2000
Status
Revoked
Jun 28, 2019
Grant Date
Mar 15, 2017
External Links
Slate, Register, Google Patents

Bibliography

The patent EP1798285B1 was granted to Alnylam Europe on Mar 15, 2017 following the initial filing on Jan 29, 2000 under the application number EP06025389A . The current legal status of the patent is Revoked.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SILENCE THERAPEUTICSDec 15, 2017ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents